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Abstract
Adherence of microbes to host tissues is a hallmark of infectious disease and is often medi-
ated by a class of adhesins termed MSCRAMMs (Microbial Surface Components Recogniz-
ing Adhesive Matrix Molecules). Numerous pathogens express MSCRAMMs that specifically
bind the heterodimeric human glycoprotein fibronectin (Fn). In addition to roles in adhesion,
Fn-binding MSCRAMMs exploit physiological Fn functions. For example, several pathogens
can invade host cells by a mechanism whereby MSCRAMM-bound Fn bridges interaction
with α5β1 integrin. Here, we investigate two Fn-binding MSCRAMMs, FnBPA (Staphylococ-
cus aureus) and BBK32 (Borrelia burgdorferi) to probe structure-activity relationships of
MSCRAMM-induced Fn/α5β1integrin activation. Circular dichroism, fluorescence resonance
energy transfer, and dynamic light scattering techniques uncover a conformational rearrange-
ment of Fn involving domains distant from theMSCRAMM binding site. Surface plasmon res-
onance experiments demonstrate a significant enhancement of Fn/α5β1 integrin affinity in the
presence of FnBPA or BBK32. Detailed kinetic analysis of these interactions reveal that this
change in affinity can be attributed solely to an increase in the initial Fn/α5β1 on-rate and that
this rate-enhancement is dependent on high-affinity Fn-binding by MSCRAMMs. These data
implicate MSCRAMM-induced perturbation of specific intramolecular contacts within the Fn
heterodimer resulting in activation by exposing previously cryptic α5β1 interaction motifs. By
correlating structural changes in Fn to a direct measurement of increased Fn/α5β1 affinity,
this work significantly advances our understanding of the structural basis for the modulation
of integrin function by Fn-binding MSCRAMMs.
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Introduction
Fibronectin (Fn) is a multidomain glycoprotein found in blood plasma, other bodily fluids and
the extra-cellular matrix (ECM) and serves as a natural ligand for several integrins including
α5β1, αvβ3, and α4β1 [1]. The functional roles of Fn are diverse and include ECM assembly,
angiogenesis, wound-repair, and oncogenesis [2]. Fn is secreted as a C-terminally disulfide-
linked heterodimer composed of three structurally defined repeating units termed Fn domains
or modules (Fig 1A). Major forms of Fn are comprised of 12 type I modules (FnI) and two
type II modules (FnII), while splice variation results in 15 to 17 type III modules (FnIII). Fn is
found in two predominant forms; cellular Fn, which is tissue localized and assembled into a
fibrillar matrix, and the hepatocyte expressed, soluble plasma Fn that is secreted and main-
tained in blood at ~0.3 mg ml-1 [3]. Despite having independent functional roles from cellular
Fn, it is significant that plasma Fn accounts for a large fraction of Fn found in tissue ECM
[3,4].
To date, over one-hundred bacterial Fn-binding proteins (FnBPs) have been reported, and a
majority of these belong to a protein family termed Microbial Surface Components Recogniz-
ing Adhesive Matrix Molecules (MSCRAMMs) [2]. Many Fn-binding MSCRAMMs contribute
to virulence as in vivo studies demonstrate a critical role for these proteins in development of
infectious diseases such as endocarditis, mastitis, and wound-infection [8–10]. A substantial
body of evidence suggests that FnBPs can also manipulate physiological functions of Fn and
thus contribute to pathogenesis in ways beyond mediating bacterial adhesion [6,11–16].
Indeed, several studies over the past decade involving the F1 and SfbI proteins from Streptococ-
cus pyogenes [11,12,17], and more recently, BBK32 from Borrelia burgdorferi [6], have led to
the development of a model whereby certain endogenous Fn activities are activated allosteri-
cally by Fn-binding MSCRAMMs. Specific intramolecular interactions exist in native plasma
Fn which hold its solution conformation in a relatively compact state [18]. These interactions
are mediated, in part, by FnI modules from the Fn-NTD fragment and FnIII modules originat-
ing from the distant Fn-CBD fragment (Fig 1A) [19–22]. Intrinsically disordered sequences
from SfbI, F1, and BBK32 engage the Fn-NTD fragment via a tandem β-zipper model of bind-
ing [6,23–25] and, in doing so, compete for these intramolecular Fn contacts [6,12,24]. This
competition results in a conformational expansion of Fn which has been directly measured
using dynamic light scattering (DLS) upon binding of SfbI [12]. Interestingly, the SfbI-induced
conformational change in Fn mirrors the transition of compact Fn to an elongated structure in
solutions of increasing ionic strength [18].
A monoclonal antibody (mAbIII-10), which recognizes a conformationally-sensitive epi-
tope within 10FnIII [26] has also been used to monitor structural changes induced in Fn by
both streptococcal and borrelial FnBPs [6,12,17]. These studies reveal a conformational rear-
rangement in Fn that occurs in domains located far outside of the FnBP/Fn binding site. The
conformational expansion of Fn induced by binding of SfbI, F1, or BBK32 has been linked to
three primary effects; (i) the 10th FnIII module of Fn which harbors the “RGD” integrin recog-
nition motif exposes a previously cryptic mAbIII-10 epitope, (ii) the motogenic “IGD” motifs
of the 7th and 9th FnI modules of the Fn-GBD fragment become exposed, and (iii) in the case of
SfbI, binding results in the blocking of Fn assembly into fibrils. In addition to binding to the
Fn-NTD fragment, SfbI, F1 and BBK32 also harbor an Fn-GBD binding site. However, Fn-
NTD interaction alone is sufficient to induce allosteric changes in Fn [12]. Consistent with this
is the recent discovery of the Streptococcus equi FnBP termed SFS, which only binds Fn via Fn-
GBD interaction, yet fails to cause conformational expansion of Fn [27].
Integrins are essential metazoan heterodimeric glycoproteins that mediate cell-adhesion,
establish transmembrane connections to the cytoskeleton, and play an integral role in cell
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signaling pathways [28]. Interestingly, integrins are common targets of pathogens and often
participate in bacterial and viral adhesion to host cells [29]. Two modes of microbial integrin
recognition have been described and include direct binding by bacterial surface proteins [30–
32] or indirect binding via physiological ligands such as Fn [29,33,34]. The latter mode is
exemplified by an FnBP expressed by the gram-positive pathogen Staphylococcus aureus,
termed FnBPA [35]. By acting as a molecular bridge, staphylococcal FnBPA exploits Fn’s role
as a natural substrate for α5β1 integrin, causing activation of endocytic pathways, and ulti-
mately resulting in the internalization of S. aureus by non-professional phagocytes [14–16,36–
45]. Full-length FnBPA harbors eleven Fn-binding repeats that specifically interact with the 2-
5FnI modules of the Fn-NTD fragment via a tandem beta-zipper [25,46] (Fig 1B). Unlike the
streptococcal and borrelial FnBPs, FnBPA binds exclusively to Fn-NTD and makes no direct
interactions with the Fn-GBD fragment. Of the 11 FnBPA Fn-binding repeats, six exhibit high-
affinity binding of Fn [46] and a single high-affinity repeat is sufficient for α5β1 integrin-depen-
dent in vitro invasion of endothelial cells by S. aureus [14].
While S. aureus is typically considered an extracellular pathogen, intracellular S. aureus is
associated with several chronic and reoccurring infections [47–50] and can establish infection
even in the presence of the vancomycin [51]. Thus, S. aureus internalized by non-professional
phagocytes represents a bacterial reservoir protected against antibiotics and innate host defense
Fig 1. Domain architectures and sequences of the polypeptides. (A) Fn is a large C-terminally disulfide
linked heterodimer that is modular in nature. Alternative splicing results in Fn monomers which are similar but
not identical [5]. For clarity, only the larger monomer is shown here. Fn consists of three domain types each
with distinct folds: FnI, FnII and FnIII (Uniprot ID: P02751). Splice variation results in a variable region (V) in a
single Fn monomer. Several functionally relevant protease-stable Fn fragments are known, including the N-
terminal domain (Fn-NTD), the gelatin-binding domain (Fn-GBD), and the cell-binding domain (Fn-CBD). The
Fn-CBD fragment harbors the canonical α5β1 “RGD” interaction motif within the 10
th FnIII module and
“synergy site” in the 9th FnIII module. Two free cysteines (SH) exist in each Fn monomer which were used to
site-specifically label the FRET probes used in this study and are located in the 7th and 15th FnIII modules.
Arrows indicate specific intramolecular interactions formed between domains of the Fn-NTD fragment and
the distant Fn-CBD fragment. (B) Domain organizations of mature FnBPA from S. aureus. The extracellular
region of FnBPA consists of an A domain that interacts with fibrinogen, followed by a sequential arrangement
of 11 Fn binding repeats, the proline-rich (PR) and cell wall (W) spanning regions, and a C-terminal sortase A
recognition motif (LPETG) (Uniprot ID: P14738). Sequence alignment of Fn-binding repeats used in this
study are shown. Highlighted in cyan are the residues within each repeat that bind to or are presumed to
engage Fn-NTD. (C) Domain organizations of mature BBK32 from B. burgdorferi (Uniprot ID: O50835). The
residues involved in binding to Fn-NTD are shown in cyan. Unlike FnBPA BBK32 also encodes a binding site
for Fn-GBD indicated by the underlined sequence [6]. The recently identified C1 binding domain is also
indicated [7]. All domains are drawn to the scale using IBS (Illustrator for Biological Sequences, http://ibs.
biocuckoo.org).
doi:10.1371/journal.pone.0159118.g001
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systems. Although it is evident that FnBPA, Fn, and α5β1 integrin work in concert to promote
an intracellular “life-style” for S. aureus [14–16,40], detailed knowledge of the underlying
molecular events that lead to invasion have remained elusive. A mechanistic understanding of
how FnBPA manipulates Fn function to enable entry of S. aureus into non-phagocytic cell
types, will benefit renewed efforts [51] to target this form of the pathogen. With this in mind,
the goals of this study were to determine if the allosteric model of Fn activation, which has
been proposed for streptococcal and borrelial FnBPs, applies to staphylococcal FnBPA. Fur-
thermore, we sought to better understand the nature of structural changes induced by Fn-bind-
ing MSCRAMMs and correlate these changes to quantitative and direct measurements of Fn/
α5β1 integrin interaction. Therefore, in parallel with our studies of FnBPA, we have also evalu-
ated the effect of borrelial BBK32 (Fig 1C) on the solution structure of Fn and its effect on
Fn/α5β1 interaction. Herein, we apply a cross-disciplinary approach to dissect the structural
basis for MSCRAMM-induced Fn activation using circular dichroism (CD), DLS, and fluores-
cence resonance energy transfer (FRET) to examine the conformational status of native Fn
or MSCRAMM-bound Fn in solution. Surface plasmon resonance (SPR) is used to quantita-
tively measure the effects of FnBPA and BBK32 on direct Fn/α5β1 interaction. Together
these experiments provide a detailed structure-activity relationship of MSCRAMM/host inter-
action and strongly suggest an allosteric mode of Fn/α5β1 affinity-enhancement for Fn-binding
MSCRAMMs.
Materials and Methods
Materials
Human Fn was purified from freshly drawn citrated plasma (Gulf Coast Regional Blood Center,
Houston, TX) using gelatin affinity chromatography combined with arginine affinity chroma-
tography as described previously [52]. Fn was stored at 4°C in Tris-buffered saline (TBS: 50 mM
Tris-HCl, pH 7.4, 150 mMNaCl), and used within one month. Fn dimer concentration was cal-
culated from OD280 nm with EC280 (1%) = 12.8 and molecular weight of 500 kDa. The ecto-
domain of integrin α5β1-Fc fusion protein, which contains the N-terminal 613 residues of α5-
subunit and fragment 121–455 of β1-subunit, was generated and purified as previously reported
[53]. Fn-NTD and Fn-CBD were purified as previously described [54]. Expression and purifica-
tion of recombinant GST-FnBPAs, FnBPA-10 peptide and BBK32(21–205) was performed as pre-
viously described [46,55]. Rabbit anti-Fn pAb (polyclonal antibody) was purchased from ICN
Pharmaceuticals, Inc. (Costa Mesa, California). BSA (bovine serum albumin), heparin sodium
(from porcine intestinal mucosa, 17,000–19,000 Da) was from Sigma.
Dynamic light scattering
DLS measurements were performed using DynaPro Titan Ambient laser unit (Wyatt Technol-
ogy Corporation) with wavelength at 828.5 nm and 10% to 12% laser power. Samples were dis-
solved in TBS and filtered through 0.22 μm filter to eliminate any particles. Fn concentration
was maintained at 0.8 mg ml-1 (1.6 μM as dimer) in TBS (50 mM Tris-HCl pH 7.4, 150 mM
NaCl) for the conditions tested. After equilibration at room temperature for 15 to 30 min, the
samples were measured three times, with each measurement lasting 100 seconds (10 acquisi-
tions, 10 seconds each). Data analysis was performed using Dynamics V6 software.
Circular Dichroism
CDmeasurements in the near UV region (350–250 nm) were carried out at ambient tempera-
ture on a Jasco J-720 spectropolarimeter (Easton, MD) with a 1 cm cell. Ten scans were
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collected and averaged at a scan speed of 200 nm min-1, with a time constant of 1 s and band
width of 1 nm. A mean residue molecular weight of 110 was used in the calculation of mean
residue ellipticity. The spectra of the Fn solution were background-corrected with the CD sig-
nal obtained from the buffer or molecules mixed with Fn.
Fluorescence resonance energy transfer
Fluorescence labeling of human plasma Fn was performed at room temperature as described
previously [56]. The fluorescence probes used in this study were purchased from Molecular
Probes. Briefly, newly purified human plasma Fn at 1.2 mg ml-1 in TBS was partly denatured in
4 M GdnHCl (Sigma) for 15 min to expose the free cysteines in the Fn dimer. The denatured
Fn was mixed with thiol-reactive Alexa Fluo1 546 C5-maleimide (AF546, ~15-fold molar
excess over Fn monomer concentration) and allowed to incubate for 2 hr with gentle rocking.
The acceptor fluorophore AF546-conjugated Fn (~0.9 mg ml-1) was labeled with a second
probe, the amine-reactive Alexa Fluo1 488 carboxylic acid-succinimidyl ester-mixed-isomers
(AF488, ~20-fold molar excess). After each labeling, the unbound dye was removed using a
PD-10 desalting column (GE Healthcare). The labeling ratios were ~8 AF488 donors and ~4
AF546 acceptors in each Fn dimer.
FRET within donor and acceptor-labeled Fn was measured using spectrofluorimeter LS 50B
(Perkin-Elmer) at room temperature with excitation wavelength at 493 nm. The sensitivity of
FRET response to the Fn unfolding was evaluated under mild denaturant (up to 2 M guanidi-
nium chloride (GdnHCl)). Measurement of MSCRAMM-induced FRET within Fn was per-
formed by titrating 0.5, 2 and 5 μl of 50 μM of BBK32 or FnBPA-10 in to 500 μl of labeled Fn.
Subsequently, the emission spectra collected for each titration was recorded and normalized to
the donor emission peak so that changes in energy transfer were reflected only by changes in
the acceptor peak. Control experiments were conducted using an equimolar solution of donor-
labeled Fn with acceptor-labeled Fn in the presence and absence of 2M GdnHCl to confirm the
absence of energy transfer between adjacent Fn molecules in solution.
SPR-based Biacore analysis of Fn and α5β1 interaction
Experiments were performed at 25°C on a Biacore 3000 (GE Healthcare Bio-Sciences AB, Upp-
sala, Sweden) using HBS-T (10 mMHEPES, pH 7.3, 150 mMNaCl, 0.005% Tween-20) con-
taining 1 mMMnCl2. To prepare sensor surface for kinetic experiments, ~1400 RU of α5β1 was
immobilized to a CM5 chip by amine coupling. Briefly, 18 μL of protein (10 μg ml-1 in 10 mM
sodium acetate, pH 4.8) was injected onto an activated (4 min activation) surface at a flow
rate of 5 μl min-1. BSA was coupled to the adjacent flow cell and served as a reference surface
(~5000 RU). A flow rate of 30 μL min-1 was used for all binding experiments. The sensor chip
surface was regenerated to remove bound Fn by injection of 1 M NaCl for 1 min. All measure-
ments were baseline corrected by subtracting the response from the reference surface. For
kinetic analysis, signals from buffer blanks were subtracted.
Kinetic constants were obtained from curve fitting to the predefined bivalent analyte model
using BIAevaluation software (Version 4.1). Heterodimeric Fn has two identical binding sites
for integrin α5β1. The reaction between soluble Fn analyte (A) and immobilized integrin ligand
(L) can be described by this equation:
Aþ L $
kd1
ka1 ALþ L $
kd2
ka2 AL2
Binding to the first ligand molecule is described by a single set of rate constants (ka1, kd1), so
that the two sites on the analyte are equivalent in the first binding step. Binding of the second
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ligand molecule is described by a second set of rate constants (ka2, kd2), which is reported in an
unconventional units of RU-1s-1. The first set of rate constants were used for calculating the dis-
sociation constant KD (KD = kd1/ka1).
ELISA-type binding assays
Experiments were conducted at room temperature and each sample was assayed in triplicate.
Immunoassay microplate Immulon 2HB (Thermo Scientific, Waltham, MA) was coated with
2 μg of integrins dissolved in TBS for 1 hour. The plate was then blocked for 1 h with 1% (w/v)
BSA in a buffer “A” (TBS containing 1 mMMnCl2). Citrated plasma (stored at -20°C for less
than 6 months) was fast-thawed at 37°C and spun to remove aggregates. The supernatant was
diluted 10-fold in buffer “A” and then mixed with varying concentrations of BBK32 to a final
concentration of 5% plasma. The sample mixtures were added onto the plate and incubated for
1 h. The plate was washed three times with buffer “B” (TBS with 1 mM, MnCl2, and 0.05%
Tween-20) before addition of rabbit anti-Fn antibody. Following washing with buffer “B”, AP-
conjugated goat-anti-rabbit IgG (BioRad, Hercules, CA) was added to the plate and incubated
for 1 h. All antibodies were diluted 2000-fold in buffer “B” containing 1% BSA. Alkaline phos-
phatase substrate PNPP (Pierce, Rockford, IL) was added after washing, and the absorbance
was measured at 405 nm using a Thermo Max plate reader (Molecular Devices, Sunnyvale,
CA).
Results
The tertiary structure of plasma Fn is altered by FnBPA and BBK32
Although high resolution crystal structures have been solved for a number of smaller Fn frag-
ments, a complete structure of full-length Fn remains to be determined. However, a wide range
of biophysical studies using DLS [18,57–61], CD [59,62,63], steady-state fluorescence spectros-
copy [59,63,64], small-angle X-ray scattering (SAXS) [65] and small-angle neutron scattering
(SANS) [60,65,66] have yielded a wealth of information about the conformational states and
structure of native Fn in solution. Conformational changes induced by FnBPs underlie the allo-
steric model of Fn activation proposed for streptococcal and borrelial FnBPs [6,12,17], and a
previous study using DLS indicates an expansion of Fn structure upon SfbI binding which is
similar to what is observed when Fn is incubated in a high salt medium [12]. To understand if
analogous conformational changes are induced by staphylococcal FnBPA we used DLS to mea-
sure the hydrodynamic radii (Rh) of Fn in the presence or absence of the FnBPA Fn-binding
repeat FnBPA-10 (Table 1). Fn adopted an extended conformation in the presence of high salt
Table 1. Comparison of hydrodynamic radii of Fn under various conditions.
Fn treatments Rh (nm)
TBS 10.20 ± 0.12
High salt 13.27 ± 0.15
Heparin 12.50 ± 0.29
FnBPA-10 12.73 ± 0.69
BBK32 13.00 ± 0.38
Dynamic light scattering measurements were performed using DynaPro Titan Ambient laser unit. Fn was
maintained in TBS at a ﬁnal concentration of 0.8 mg ml-1 (1.6 μM) for the conditions tested. Different
treatments are additional 350 mM NaCl (high salt), 15 μM of heparin, FnBPA-10 peptide, or 6 μM of BBK32
recombinant protein. Values are mean ± SE obtained from a minimum of three independent experiments.
doi:10.1371/journal.pone.0159118.t001
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or heparin (Rh = 13.27 ± 0.15; 12.50 ± 0.29, respectively) compared to a more compact struc-
ture found in physiological buffer (Rh = 10.20 ± 0.12) which is consistent with previous mea-
surements of Fn Rh by DLS [12,18]. Addition of staphylococcal FnBPA-10 (Rh = 12.73 ± 0.69)
or the borrelial FnBP, BBK32 (Rh = 13.00 ± 0.38) resulted in a significantly increased Rh, sug-
gesting that Fn indeed adopts an extended structure upon binding to these MSCRAMMs.
Native Fn contains large numbers of aromatic residues in its type I and III domains which
exist in common hydrophobic environments and give rise to a signature near-UV CD spec-
trum characterized by two strong negative peaks centered at 291 nm and 299 nm, and a weaker
negative peak at 282 nm (Fig 2) [67,68]. Binding of Fn by the glycosaminoglycan heparin has
been shown to alter Fn tertiary structure which can be monitored by shifts in this signature
spectrum (Fig 2) [69]. When Fn was incubated in the presence of FnBPA-10 or BBK32, both
complexes produce significantly different spectra relative to native Fn (Fig 2). Interestingly we
noted the similarity in the near-UV spectra for heparin-bound Fn when compared to FnBPA-
10/Fn (Fig 2), whereas, the BBK32 spectrum is reminiscent of the partial unfolding of Fn in 4M
urea [63]. Importantly, the MSCRAMM fragments used in these experiments are intrinsically
disordered polypeptides that do not contain tryptophan residues and therefore lack near-UV
optical activity [70] (Fig 2). However, since the Fn-NTD is engaged by BBK32 and FnBPA-10,
such interaction could potentially cause near-UV CD optical activity changes within NTD
domain. As shown in S1 Fig, BBK32 and FnBPA-10 caused intrinsic Trp fluorescence quench-
ing in Fn (S1A Fig) and Fn-NTD (S1B Fig), suggesting that Trp environments in the NTD and
GBD (in the case for BBK32) are affected by the binding and may attribute partially to the
near-UV CD changes in Fn.
Data obtained using an anti-Fn antibody (mAb10-III) that recognizes a conformational sen-
sitive epitope indicates that structural changes distant from the streptococcal and borrelial
FnBP binding site are induced in Fn [6,12,17] on MSCRAMM binding. To learn if FnBPA
causes similar allosteric changes in Fn upon binding, and to confirm apparent conformational
changes in solution Fn indicated by CD (Fig 2), we next employed a FRET-based approach. To
this end, Fn was site-specifically labelled by conjugating an acceptor fluorophore to free cyste-
ine residues using a technique previously described [56]. Native Fn contains only two free cys-
teines (4 per dimer molecule) and these are found in the C-terminally positioned 7FnIII and
15FnIII modules [71] (denoted in Fig 1A). When Fn is denatured by introducing increasing
amounts of GdnHCl (Fig 3A and 3B), or incubated in the presence of increasing ionic strength
(Fig 3C), the distance between the amine coupled donor fluorophores and the cysteine coupled
acceptor fluorophores increased and the acceptor peak was diminished. There is not FRET
Fig 2. Near-UV CD spectra of Fn. CD spectra in the range of 250–350 nm are shown for individual
molecules or mixtures: Fn dimer (0.82 mg ml-1, 1.6 μM), BBK32 (0.14 mg ml-1, 6.0 μM), FnBPA-10 (0.07 mg
ml-1, 15 μM), and heparin (0.27 mg ml-1, 15 μM). All concentrations are final. TBS (50 mM Tris-HCl pH 7.4,
150 mMNaCl) was used for all experiments.
doi:10.1371/journal.pone.0159118.g002
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observed between adjacent or denatured Fn molecules (Fig 3D). To determine if the
MSCRAMM-induced structural changes measured by CD and DLS involve Fn domains out-
side of the MSCRAMM binding site, spectra were then collected in the presence of various con-
centrations of BBK32 (Fig 3E) and FnBPA-10 (Fig 3F) GST fusion proteins. These experiments
showed a clear dose-dependent loss of acceptor peak signal for MSCRAMM-bound Fn. Impor-
tantly, an identical effect is observed when a 36 amino acid peptide lacking the GST fusion and
corresponding to the high-affinity FnBPA repeat FnBPA-5 is used (Fig 3G). GST alone or a
GST fusion to the low-affinity FnBPA repeat FnBPA-3 exhibits no effect in this assay system
(Fig 3H). Taken together, the DLS, CD, and fluorescence based assays indicated that BBK32
and FnBPA profoundly modify the native solution structure of Fn by promoting an extended
Fn conformation that results in large scale rearrangement of Fn domains at sites distant from
the MSCRAMM binding site.
Fn recognition of the α5β1 integrin is enhanced by FnBPA and BBK32
Fn serves as a primary ECM substrate for several adhesion molecules including the major Fn
cell surface receptor, α5β1 integrin [1]. We hypothesized that conformational changes induced
upon binding by FnBPA or BBK32, as shown in Figs 2 and 3 and Table 1, may result in modi-
fied Fn/integrin interactions. Previous studies on streptococcal and borrelial Fn-binding
MSCRAMMs have used the conformational Fn antibody (mAb10-III) as a surrogate for poten-
tial effects on Fn/α5β1 integrin interaction. To test this more directly, we developed an SPR-
based system to study the effects of FnBPA and BBK32 on the recognition of α5β1 integrin by
Fn. Briefly, a recombinant α5β1-Fc fusion protein representing the minimal functional unit of
the integrin [53] was immobilized on the surface of a Biacore CM5 chip. Fn interacts with the
α5β1 biosensor and binding is enhanced by Mn
2+ as previously reported (S1A Fig) [53]. Further
validation of this experimental approach was performed by using Fn fragments including the
cell-binding domain (Fn-CBD) possessing the canonical α5β1-binding “RGD” (
10FnIII) and
PSHRN synergy sites (9FnIII) [72,73]. As expected, the Fn-CBD fragment exhibited dose-
Fig 3. Fluorescent resonance energy transfer of Fn. Fluorescence emission spectra of Fn-D/A (50 nM in
10 mM Tris, pH7.4, 150 mMNaCl) were collected at 493 nm excitation, (A) in the presence or absence of
denaturant (GdnHCl) and (B) accompanying Acceptor/Donor peak ratio as a function of denaturant
concentration. Fn-D/A fluorescence emission changes (C) under different ionic strengths, and (E-G) in the
presence of different concentrations of BBK32, GST-FnBPA-10, or FnBPA-5 peptide. (H) Acceptor/Donor
peak ratio vs. concentration (0, 1, 5, 20, 50 and 200 nM) of protein or peptide added. Spectra are normalized
to the donor emission peak at 522 nm such that changes in energy transfer are reflected only by changes in
the acceptor peak at 570 nm. (D) Control experiments were conducted by mixing 50 nM of donor-labeled Fn
(Fndonor) with 50 nM of acceptor-labeled Fn (Fnacceptor) in TBS or 2 M GdnHCl.
doi:10.1371/journal.pone.0159118.g003
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dependent interaction with α5β1, while the Fn-NTD fragment lacking the integrin interaction
domains failed to bind the integrin (S1B and S1C Fig).
Using this approach we measured a moderate affinity of ~1 μM for Fn/α5β1 (Fig 4A–4D)
that is in good agreement with affinities reported for fibroblast cell interaction with plasma Fn
[74]. To understand if MSCRAMM binding to Fn affects the Fn/α5β1 interaction, we next
injected mixtures of BBK32/Fn or FnBPA-10/Fn (fixed MSCRAMM + varied Fn concentra-
tions) over the immobilized α5β1 integrin. A remarkable enhancement of the binding response
was observed for MSCRAMM-bound Fn relative to native Fn (Fig 4B–4D). To obtain a quanti-
tative measure of the increase in affinity, kinetic parameters were obtained by fitting SPR
response curves to a bivalent analyte binding model (Fig 4B–4D). This model was selected on
the basis of closeness of fit (χ21, Table 1) and the expectation that dimeric Fn contributes one
identical α5β1 binding site per subunit. Analysis for each interaction revealed that the approxi-
mately five-fold increase in apparent affinity (KD) (KD
Fn/α5β1 = 1000 nM vs. KD
BBK32/Fn/α5β1 =
170 nM & KD
FnBPA-10/Fn/α5β1 = 260 nM) was due to an increase in the initial association rate
([ka1 = (1.5, 6.1, & 7.5) x10
4 M-1s-1], respectively). Interestingly, all other rate constants (kd1,
ka2 and kd2) (Table 2) were similar across experiments, indicating that the Fn/α5β1 binding site
present in native Fn is the same for MSCRAMM-bound Fn.
To address the specificity of enhanced Fn/α5β1 activity and to further dissect the kinetic
observations presented above, we next injected a mixture of varied MSCRAMM and fixed Fn
concentrations (Fig 5A–5C). Again we observed an increase in response that behaved in a
dose-dependent and saturable manner, similar to the results obtained in Fig 4B–4D. Likewise,
only the initial association rate ka1 was changed, while the stability of the complex (kd1), the
second rate step (ka2 and kd2), and maximum response when all the binding sites on active α5β1
are saturated (Rmax) were unaffected by the presence of MSCRAMMs (Fig 5B–5D). The initial
Fig 4. SPR analysis of direct Fn/α5β1 interaction in the presence of Fn-binding MSCRAMMs. (A) Two-
fold linear dilution series of Fn in HBS-T containing 1 mMMnCl2, and in the presence of (B) 1 μM of FnBPA-
10, or (C) 0.5 μM of BBK32 were injected over the α5β1 biosensor. (D) A higher Fn concentration series was
used for measurement of Fn/α5β1 binding kinetics in the absence of MSCRAMMs. The SPR response curves
generated from Fn binding to α5β1 are shown in black with lower curve corresponding to lower concentration
of Fn injected. Dissociation constants (KD) for Fn/α5β1 the interaction (B-D)were obtained from fitting SPR
response curves to a bivalent analyte binding model (fitted lines are shown in red) and the kinetic parameters
are listed in Table 2. There was no detectable binding when FnBPA-10 (1 μM) or BBK32 (0.5 μM) were
injected over the same α5β1 surface (data not shown).
doi:10.1371/journal.pone.0159118.g004
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association rate, ka1, is the only kinetic parameter directly affected by analyte concentration
(units = M-1s-1). As the concentrations of Fn used across experiments were the same, the
observed increase in ka1 for Fn bound by increasing concentrations of MSCRAMMs likely rep-
resents an increase in the apparent concentration of the active integrin binding site in Fn.
High-affinity FnBPA/Fn-NTD interaction is required for enhancement of
Fn/α5β1 activity
Of the eleven Fn-binding repeats found in FnBPA, six have been characterized as high-affinity
binders (FnBPA-1, -4, -5, -9, -10, -11). The higher affinity of these repeats has been attributed
to their ability to interact with four sequential FnI modules of the Fn-NTD fragment [46]. For
example, while FnBPA-10 contains correctly spaced motifs to interact with 2-5FnI in a β-tan-
dem zipper model of binding, the low-affinity repeat FnBPA-3 appears to lack the 5FnI interac-
tion motif. Intriguingly, these particular Fn modules have been implicated in mediating long-
range intra-molecular contacts within native Fn dimers (Fig 1A) [19,21,22]. To understand if
high-affinity interaction is required for an MSCRAMM-induced increase in Fn/α5β1 recogni-
tion, we next tested a panel of high and low-affinity FnBPA repeats (Fig 6). All high-affinity
Table 2. Kinetic parameters for Fn::α5β1 interactions.
Analyte injected ka1(×104 M-1s-1) kd1 (×10−2 s-1) ka2 (×10−5 RU-1s-1) kd2 (×10−3 s-1) KD (nM) χ 2
Fn alone 1.5 ± 0.0 1.5 ± 0.0 1.1 ± 0.1 0.9 ± 0.0 1000 ± 130 1.15 ± 0.26
Fn + FnBPA-10 6.1 ± 0.6 1.5 ± 0.2 1.3 ± 0.3 1.0 ± 0.1 260 ± 90 1.10 ± 0.29
Fn + BBK32 7.5 ± 0.8 1.2 ± 0.2 0.8 ± 0.0 1.0 ± 0.1 170 ± 90 1.04 ± 0.42
Association (ka1, ka2) and dissociation rate (kd1, kd2) constants obtained from ﬁtting SPR response curves (Fig 4B–4D) to a bivalent analyte binding model.
The statistical value χ2 is also listed to show the closeness of each ﬁt. Values are mean values (with standard error in parentheses) obtained from at least
three experiments.
doi:10.1371/journal.pone.0159118.t002
Fig 5. SPR analysis of kinetic components of the Fn/α5β1 interaction that are affected by MSCRAMMs.
Fn (50 nM) in the presence of indicated concentration of (A) FnBPA-10 or (C) BBK32 was injected over an
α5β1 surface on a Biacore sensor chip. Kinetic components (ka1, kd1, ka2, kd2) and Rmax obtained from local
fitting were normalized to those of Fn alone, and plotted as a function of (B) FnBPA-10 or (D) BBK32
concentrations.
doi:10.1371/journal.pone.0159118.g005
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repeats studied (FnBPA-1, -5, -9, -10, and -11) increased the Fn/α5β1 binding response, while
the low-affinity repeat FnBPA-3 exhibited control-level signal.
MSCRAMMs enhance Fn/α5β1 interaction in human plasma
The SPR-based activity assay utilizing purified native and recombinant reagents allowed for a
quantitative kinetic assessment of the MSCRAMM-induced enhancement of Fn/α5β1 binding.
We next asked if this effect could be recapitulated using human plasma as a source of native
Fn. Indeed, an MSCRAMM-dependent increase in plasma Fn/α5β1 binding was observed in
the presence of FnBPA-10 or and to a greater extent for BBK32 when 5% human plasma
(~15 μg ml-1 or equivalently ~30 nM Fn) was used in an ELISA-type binding assay (Fig 7).
Discussion
Modeling the allosteric activation of Fn/α5β1 by Fn-binding MSCRAMMs
By manipulating the conformation of key Fn functional domains, Fn-binding MSCRAMMs
enable pathogens to hijack normal host physiology. In the case of S. aureus, enhanced Fn/α5β1
interaction leads to recruitment of focal contact-associated proteins and subsequent integrin
clustering at the bacterial attachment site initiates intracellular signaling through the focal
adhesion kinase (FAK) and Src kinases [33,43,75]. This appears to confer an advantage to S.
aureus by facilitating immune evasion and serves as a bacterial reservoir in chronic infections
Fig 6. Relationship of high affinity Fn-NTD fragment interaction and α5β1 integrin activation. SPR
sensorgrams were generated by injecting 50 nM Fn in the presence of GST-fused FnBPA repeats (0.5 μM for
high-affinity repeats -1, -5, -9, -10, -11 and 15 μM for low affinity repeat -3) over immobilized α5β1. The KD
reported for direct binding of Fn-NTD by high affinity FnBPA repeats are provided for reference and were
obtained from previously published isothermal titration calorimetry (ITC) experiments [46]. The weak affinity
between FnBPA-3 and Fn-NTD was measured by SPR (this work, data not shown). None of the repeats
bound directly to α5β1 (data not shown).
doi:10.1371/journal.pone.0159118.g006
Fig 7. ELISA detection of the effect of MSCRAMMs on intact Fn in plasma for α5β1 binding. 5% human
blood plasma in TBS containing 1 mMMnCl2 was incubated with (A) FnBPA-10 or (B) BBK32, and added
α5β1-coated wells or BSA (0.2 μg per well) coated surfaces. Bound Fn was probed with anti-Fn pAb. BBK32
did not bind directly to α5β1 when detected by anti-BBK32 pAb (data not shown). Data are one representative
of three experiments.
doi:10.1371/journal.pone.0159118.g007
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[33,51]. In light of the observations above, we propose a model for the allosteric enhancement
of Fn/α5β1 binding by staphylococcal FnBPA (Fig 8), similar to that put forward for streptococ-
cal and borrelial FnBPs [6,12,13,17]. We speculate that dimeric native Fn exists as an array of
conformers in solution. At equilibrium, predominate forms of Fn are compact and sterically
occlude α5β1 interaction domains (
9FnIII-10FnIII) by long-range intramolecular interactions,
thereby impeding Fn/α5β1 recognition. The equilibrium of Fn conformers shifts upon high-
affinity binding of FnBPA and native intramolecular contacts are disrupted exposing previ-
ously cryptic α5β1 binding sites and promoting Fn/α5β1 binding. Domains involved in integrin
binding by Fn are located at a site distant from the MSCRAMM binding site. It appears then
that a critical feature of MSCRAMM-induced activation of Fn/α5β1 is allostery and allosteric
modes of host protein modulation have been previously reported for S. aureus [76]. Our find-
ings also suggest that the conformation of integrin ligands, like Fn, may fine-tune affinities
and therefore contribute to integrin “activation” traditionally associated with conformational
change of the integrin ectodomains [77].
The data presented here provides a foundation to study the potential involvement of Fn-
binding MSCRAMMs in several aspects of Fn physiology. In addition to Fn/integrin interac-
tion, cryptic functional sites in Fn play a fundamental role in mechanoresponsive and moto-
genic pathways [19,78]. Interestingly, polymorphisms have been recently reported in two high-
affinity FnBPA repeats (FnBPA-5 and -9) and S. aureus strains harboring these mutations are
highly correlated with infection of cardiovascular devices [79,80]. How these FnBPA mutations
impact bound Fn tertiary structure is currently unknown, however, we predict that sequence
changes to residues in FnBPA repeats could result in different global Fn structure and thus
function. Finally, as the clinical relevance of intracellular forms of S. aureus are becoming
Fig 8. An allosteric model of Fn activation by MSCRAMMs. Based on the data presented here and the
previously proposed allosteric model of Fn activation by streptococcal and borrelial FnBPs [6,12,17], we
constructed the above model for allosteric affinity enhancement of the Fn/α5β1 interaction by staphylococcal
FnBPA. Fn is represented in its native state (left) or bound by FnBPA (right). The native Fn model including
intermolecular contacts are adapted from a previously proposedmodel based on multiple independent
studies. In a native state, major solution conformations of Fn occlude the canonical α5β1 interaction motifs
located in 9-10FnIII domains. Upon binding to Fn, FnBPA disrupts specific intermolecular contacts in the N-
terminal domain of Fn (Fn-NTD) resulting in global structural rearrangements at sites distant from the FnBPA
binding site. Previously cryptic integrin interaction sites are exposed, promoting interaction of Fn with α5β1.
This initiates ‘outside-in’ signaling events leading to cytoskeletal rearrangement and eventual internalization
of Fn-coated S. aureus.
doi:10.1371/journal.pone.0159118.g008
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clearer [51], elucidation of the molecular mechanisms of Fn-binding MSCRAMMs, like
FnBPA, stands to provide a major contribution towards improving the treatment of staphylo-
coccal infectious diseases.
Supporting Information
S1 Fig. Steady-state fluorescence spectroscopy. Intrinsic tryptophan fluorescence spectra of
Fn solutions were obtained on a Spectrofluorimeter LS 50B (Perkin-Elmer) at ambient temper-
ature. (A) Fn (0.1 μM) was incubated in TBS in the presence of 1 M GdnHCl, 0.2 μM BBK32 or
2 μM of FnBPA-10. (B) FnNTD-30K (1.6 μM) were incubated in TBS in the presence of 16 μM
of FnBPA-10. Samples were excited at 295 nm with and excitation slit of 5 nm, and emission
spectra were collected with an emission slit of 5 nm. All spectra were corrected for background
fluorescence by subtraction of the buffer blanks.
(TIF)
S2 Fig. SPR analysis of Fn/α5β1 interaction. The α5β1 biosensor was validated by demonstrat-
ing metal ion dependence and domain specificity: (A) Fn (250 nM) was injected over immobi-
lized α5β1 surface in the presence of 1 mMMnCl2 (solid line) or 3 mM EDTA (dashed line).
(B) Response curves for a two-fold linear dilution series of Fn-CBD over immobilized α5β1
are shown. (C) Comparison of Fn (250 nM, solid line) and the Fn-NTD fragment lacking the
canonical integrin binding RGD-motif (500 nM, dashed line).
(TIFF)
Acknowledgments
The authors are grateful for Susan E. Craig from the Wellcome Trust Centre for CellMatrix
Research at University of Manchester for the recombinant integrin α5β1.
Author Contributions
Conceived and designed the experiments: MH XL. Performed the experiments: XL. Analyzed
the data: MH XL BLG. Contributed reagents/materials/analysis tools: SP LV NAGMMJH JRP.
Wrote the paper: MH XL BLG.
References
1. Leiss M, Beckmann K, Giros A, Costell M, Fassler R. The role of integrin binding sites in fibronectin
matrix assembly in vivo. Curr Opin Cell Biol. 2008; 20: 502–507. doi: 10.1016/j.ceb.2008.06.001 PMID:
18586094
2. Henderson B, Nair S, Pallas J, Williams MA. Fibronectin: a multidomain host adhesin targeted by bacte-
rial fibronectin-binding proteins. FEMSMicrobiol Rev. 2011; 35: 147–200. doi: 10.1111/j.1574-6976.
2010.00243.x PMID: 20695902
3. Moretti FA, Chauhan AK, Iaconcig A, Porro F, Baralle FE, Muro AF. A major fraction of fibronectin pres-
ent in the extracellular matrix of tissues is plasma-derived. J Biol Chem. 2007; 282: 28057–28062.
M611315200 [pii]. PMID: 17644525
4. ToWS, Midwood KS. Plasma and cellular fibronectin: distinct and independent functions during tissue
repair. Fibrogenesis Tissue Repair. 2011; 4: 21-1536-4-21. doi: 10.1186/1755-1536-4-21
5. Peters JH, Loredo GA, Chen G, Maunder R, Hahn TJ, Willits NH, et al. Plasma levels of fibronectin
bearing the alternatively spliced EIIIB segment are increased after major trauma. J Lab Clin Med. 2003;
141: 401–410. doi: 10.1016/S0022-2143(03)00042-8 PMID: 12819638
6. Harris G, MaW, Maurer LM, Potts JR, Mosher DF. Borrelia burgdorferi protein BBK32 binds to soluble
fibronectin via the N-terminal 70-kDa region, causing fibronectin to undergo conformational extension.
J Biol Chem. 2014; 289: 22490–22499. doi: 10.1074/jbc.M114.578419 PMID: 24962582
Allosteric Enhancement of Fn/α5β1 Affinity by FnBPA and BBK32
PLOSONE | DOI:10.1371/journal.pone.0159118 July 19, 2016 13 / 17
7. Garcia BL, Zhi H, Wager B, Hook M, Skare JT. Borrelia burgdorferi BBK32 Inhibits the Classical Path-
way by Blocking Activation of the C1 Complement Complex. PLoS Pathog. 2016; 12: e1005404. doi:
10.1371/journal.ppat.1005404 PMID: 26808924
8. Heying R, van de Gevel J, Que YA, Moreillon P, Beekhuizen H. Fibronectin-binding proteins and clump-
ing factor A in Staphylococcus aureus experimental endocarditis: FnBPA is sufficient to activate human
endothelial cells. Thromb Haemost. 2007; 97: 617–626. 07040617 [pii]. PMID: 17393025
9. Fisher M, Huang YS, Li X, McIver KS, Toukoki C, Eichenbaum Z. Shr is a broad-spectrum surface
receptor that contributes to adherence and virulence in group A streptococcus. Infect Immun. 2008; 76:
5006–5015. doi: 10.1128/IAI.00300-08 PMID: 18710861
10. Brouillette E, Talbot BG, Malouin F. The fibronectin-binding proteins of Staphylococcus aureus may
promote mammary gland colonization in a lactating mouse model of mastitis. Infect Immun. 2003; 71:
2292–2295. PMID: 12654860
11. Marjenberg ZR, Ellis IR, Hagan RM, Prabhakaran S, Hook M, Talay SR, et al. Cooperative binding and
activation of fibronectin by a bacterial surface protein. J Biol Chem. 2011; 286: 1884–1894. doi: 10.
1074/jbc.M110.183053 PMID: 21059652
12. Maurer LM, MaW, Eickstaedt NL, Johnson IA, Tomasini-Johansson BR, Annis DS, et al. Ligation of the
fibrin-binding domain by beta-strand addition is sufficient for expansion of soluble fibronectin. J Biol
Chem. 2012; 287: 13303–13312. doi: 10.1074/jbc.M111.294041 PMID: 22351755
13. Maurer LM, Tomasini-Johansson BR, MaW, Annis DS, Eickstaedt NL, Ensenberger MG, et al.
Extended binding site on fibronectin for the functional upstream domain of protein F1 of Streptococcus
pyogenes. J Biol Chem. 2010; 285: 41087–41099. doi: 10.1074/jbc.M110.153692 PMID: 20947497
14. Edwards AM, Potts JR, Josefsson E, Massey RC. Staphylococcus aureus host cell invasion and viru-
lence in sepsis is facilitated by the multiple repeats within FnBPA. PLoS Pathog. 2010; 6: e1000964.
doi: 10.1371/journal.ppat.1000964 PMID: 20585570
15. Edwards AM, Potter U, Meenan NA, Potts JR, Massey RC. Staphylococcus aureus keratinocyte inva-
sion is dependent upon multiple high-affinity fibronectin-binding repeats within FnBPA. PLoS One.
2011; 6: e18899. doi: 10.1371/journal.pone.0018899 PMID: 21526122
16. Massey RC, Kantzanou MN, Fowler T, Day NP, Schofield K, Wann ER, et al. Fibronectin-binding pro-
tein A of Staphylococcus aureus has multiple, substituting, binding regions that mediate adherence to
fibronectin and invasion of endothelial cells. Cell Microbiol. 2001; 3: 839–851. 157 [pii]. PMID:
11736995
17. Ensenberger MG, Annis DS, Mosher DF. Actions of the functional upstream domain of protein F1 of
Streptococcus pyogenes on the conformation of fibronectin. Biophys Chem. 2004; 112: 201–207.
S0301-4622(04)00188-7 [pii]. PMID: 15572249
18. Nelea V, Nakano Y, Kaartinen MT. Size distribution and molecular associations of plasma fibronectin
and fibronectin crosslinked by transglutaminase 2. Protein J. 2008; 27: 223–233. doi: 10.1007/s10930-
008-9128-1 PMID: 18330684
19. Vakonakis I, Staunton D, Ellis IR, Sarkies P, Flanagan A, Schor AM, et al. Motogenic sites in human
fibronectin are masked by long range interactions. J Biol Chem. 2009; 284: 15668–15675. doi: 10.
1074/jbc.M109.003673 PMID: 19366708
20. Johnson KJ, Sage H, Briscoe G, Erickson HP. The compact conformation of fibronectin is determined
by intramolecular ionic interactions. J Biol Chem. 1999; 274: 15473–15479. PMID: 10336438
21. Bultmann H, Santas AJ, Peters DM. Fibronectin fibrillogenesis involves the heparin II binding domain of
fibronectin. J Biol Chem. 1998; 273: 2601–2609. PMID: 9446562
22. Homandberg GA, Erickson JW. Model of fibronectin tertiary structure based on studies of interactions
between fragments. Biochemistry. 1986; 25: 6917–6925. PMID: 3801402
23. Raibaud S, Schwarz-Linek U, Kim JH, Jenkins HT, Baines ER, Gurusiddappa S, et al. Borrelia burgdor-
feri binds fibronectin through a tandem beta-zipper, a commonmechanism of fibronectin binding in
staphylococci, streptococci, and spirochetes. J Biol Chem. 2005; 280: 18803–18809. M501731200
[pii]. PMID: 15737988
24. Norris NC, Bingham RJ, Harris G, Speakman A, Jones RP, Leech A, et al. Structural and functional
analysis of the tandem beta-zipper interaction of a Streptococcal protein with human fibronectin. J Biol
Chem. 2011; 286: 38311–38320. doi: 10.1074/jbc.M111.276592 PMID: 21840989
25. Schwarz-Linek U, Werner JM, Pickford AR, Gurusiddappa S, Kim JH, Pilka ES, et al. Pathogenic bacte-
ria attach to human fibronectin through a tandem beta-zipper. Nature. 2003; 423: 177–181. doi: 10.
1038/nature01589 PMID: 12736686
26. Ugarova TP, Zamarron C, Veklich Y, Bowditch RD, Ginsberg MH, Weisel JW, et al. Conformational
transitions in the cell binding domain of fibronectin. Biochemistry. 1995; 34: 4457–4466. PMID:
7535564
Allosteric Enhancement of Fn/α5β1 Affinity by FnBPA and BBK32
PLOSONE | DOI:10.1371/journal.pone.0159118 July 19, 2016 14 / 17
27. MaW, Ma H, Fogerty FJ, Mosher DF. Bivalent ligation of the collagen-binding modules of fibronectin by
SFS, a non-anchored bacterial protein of Streptococcus equi. J Biol Chem. 2015; 290: 4866–4876. doi:
10.1074/jbc.M114.612259 PMID: 25525266
28. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002; 110: 673–687.
S0092867402009716 [pii]. PMID: 12297042
29. Hauck CR, Borisova M, Muenzner P. Exploitation of integrin function by pathogenic microbes. Curr
Opin Cell Biol. 2012; 24: 637–644. doi: 10.1016/j.ceb.2012.07.004 PMID: 22884865
30. Coburn J, ChegeW, Magoun L, Bodary SC, Leong JM. Characterization of a candidate Borrelia burg-
dorferi beta3-chain integrin ligand identified using a phage display library. Mol Microbiol. 1999; 34:
926–940. mmi1654 [pii]. PMID: 10594819
31. Kwok T, Zabler D, Urman S, Rohde M, Hartig R, Wessler S, et al. Helicobacter exploits integrin for
type IV secretion and kinase activation. Nature. 2007; 449: 862–866. nature06187 [pii]. PMID:
17943123
32. Isberg RR, Leong JM. Multiple beta 1 chain integrins are receptors for invasin, a protein that promotes
bacterial penetration into mammalian cells. Cell. 1990; 60: 861–871. 0092-8674(90)90099-Z [pii].
PMID: 2311122
33. Hauck CR, Ohlsen K. Sticky connections: extracellular matrix protein recognition and integrin-mediated
cellular invasion by Staphylococcus aureus. Curr Opin Microbiol. 2006; 9: 5–11. S1369-5274(05)
00196-7 [pii]. PMID: 16406780
34. Hoffmann C, Ohlsen K, Hauck CR. Integrin-mediated uptake of fibronectin-binding bacteria. Eur J Cell
Biol. 2011; 90: 891–896. doi: 10.1016/j.ejcb.2011.03.001 PMID: 21561684
35. Foster TJ, Hook M. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol. 1998; 6:
484–488. S0966-842X(98)01400-0 [pii]. PMID: 10036727
36. Sinha B, Francois PP, Nusse O, Foti M, Hartford OM, Vaudaux P, et al. Fibronectin-binding protein acts
as Staphylococcus aureus invasin via fibronectin bridging to integrin alpha5beta1. Cell Microbiol. 1999;
1: 101–117. cmi11 [pii]. PMID: 11207545
37. Dziewanowska K, Patti JM, Deobald CF, Bayles KW, TrumbleWR, Bohach GA. Fibronectin binding
protein and host cell tyrosine kinase are required for internalization of Staphylococcus aureus by epi-
thelial cells. Infect Immun. 1999; 67: 4673–4678. PMID: 10456915
38. Lammers A, Nuijten PJ, Smith HE. The fibronectin binding proteins of Staphylococcus aureus are
required for adhesion to and invasion of bovine mammary gland cells. FEMSMicrobiol Lett. 1999; 180:
103–109. S0378-1097(99)00470-X [pii]. PMID: 10547450
39. Fowler T, Wann ER, Joh D, Johansson S, Foster TJ, Hook M. Cellular invasion by Staphylococcus
aureus involves a fibronectin bridge between the bacterial fibronectin-binding MSCRAMMs and host
cell beta1 integrins. Eur J Cell Biol. 2000; 79: 672–679. PMID: 11089915
40. Schroder A, Schroder B, Roppenser B, Linder S, Sinha B, Fassler R, et al. Staphylococcus aureus
fibronectin binding protein-A induces motile attachment sites and complex actin remodeling in living
endothelial cells. Mol Biol Cell. 2006; 17: 5198–5210. E06-05-0463 [pii]. PMID: 17021255
41. Sinha B, Francois P, Que YA, Hussain M, Heilmann C, Moreillon P, et al. Heterologously expressed
Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells. Infect
Immun. 2000; 68: 6871–6878. PMID: 11083807
42. Sinha B, Herrmann M. Mechanism and consequences of invasion of endothelial cells by Staphylococ-
cus aureus. Thromb Haemost. 2005; 94: 266–277. 05080266 [pii]. PMID: 16113815
43. Agerer F, Lux S, Michel A, Rohde M, Ohlsen K, Hauck CR. Cellular invasion by Staphylococcus aureus
reveals a functional link between focal adhesion kinase and cortactin in integrin-mediated internalisa-
tion. J Cell Sci. 2005; 118: 2189–2200. jcs.02328 [pii]. PMID: 15855238
44. Shinji H, Yosizawa Y, Tajima A, Iwase T, Sugimoto S, Seki K, et al. Role of fibronectin-binding proteins
A and B in in vitro cellular infections and in vivo septic infections by Staphylococcus aureus. Infect
Immun. 2011; 79: 2215–2223. doi: 10.1128/IAI.00133-11 PMID: 21422173
45. Kerdudou S, Laschke MW, Sinha B, Preissner KT, Menger MD, Herrmann M. Fibronectin binding pro-
teins contribute to the adherence of Staphylococcus aureus to intact endothelium in vivo. Thromb Hae-
most. 2006; 96: 183–189. 06080183 [pii]. PMID: 16894462
46. Meenan NA, Visai L, Valtulina V, Schwarz-Linek U, Norris NC, Gurusiddappa S, et al. The tandem
beta-zipper model defines high affinity fibronectin-binding repeats within Staphylococcus aureus
FnBPA. J Biol Chem. 2007; 282: 25893–25902. M703063200 [pii]. PMID: 17606607
47. Bosse MJ, Gruber HE, RampWK. Internalization of bacteria by osteoblasts in a patient with recurrent,
long-term osteomyelitis. A case report. J Bone Joint Surg Am. 2005; 87: 1343–1347. 87/6/1343 [pii].
PMID: 15930546
Allosteric Enhancement of Fn/α5β1 Affinity by FnBPA and BBK32
PLOSONE | DOI:10.1371/journal.pone.0159118 July 19, 2016 15 / 17
48. Clement S, Vaudaux P, Francois P, Schrenzel J, Huggler E, Kampf S, et al. Evidence of an intracellular
reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis. J Infect
Dis. 2005; 192: 1023–1028. JID34531 [pii]. PMID: 16107955
49. Jarry TM, Memmi G, Cheung AL. The expression of alpha-haemolysin is required for Staphylococcus
aureus phagosomal escape after internalization in CFT-1 cells. Cell Microbiol. 2008; 10: 1801–1814.
doi: 10.1111/j.1462-5822.2008.01166.x PMID: 18466345
50. Que YA, Haefliger JA, Piroth L, Francois P, Widmer E, Entenza JM, et al. Fibrinogen and fibronectin
binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis.
J Exp Med. 2005; 201: 1627–1635. jem.20050125 [pii]. PMID: 15897276
51. Lehar SM, Pillow T, Xu M, Staben L, Kajihara KK, Vandlen R, et al. Novel antibody-antibiotic conjugate
eliminates intracellular S. aureus. Nature. 2015; 527: 323–328. doi: 10.1038/nature16057 PMID:
26536114
52. Speziale P, Visai L, Rindi S, Di Poto A. Purification of human plasma fibronectin using immobilized gel-
atin and Arg affinity chromatography. Nat Protoc. 2008; 3: 525–533. doi: 10.1038/nprot.2008.12 PMID:
18323821
53. Coe AP, Askari JA, Kline AD, Robinson MK, Kirby H, Stephens PE, et al. Generation of a minimal
alpha5beta1 integrin-Fc fragment. J Biol Chem. 2001; 276: 35854–35866. doi: 10.1074/jbc.
M103639200 PMID: 11389148
54. Zardi L, Carnemolla B, Balza E, Borsi L, Castellani P, Rocco M, et al. Elution of fibronectin proteolytic
fragments from a hydroxyapatite chromatography column. A simple procedure for the purification of
fibronectin domains. Eur J Biochem. 1985; 146: 571–579. PMID: 2982601
55. Prabhakaran S, Liang X, Skare JT, Potts JR, Hook M. A novel fibronectin binding motif in MSCRAMMs
targets F3 modules. PLoS One. 2009; 4: e5412. doi: 10.1371/journal.pone.0005412 PMID: 19404402
56. Baneyx G, Baugh L, Vogel V. Coexisting conformations of fibronectin in cell culture imaged using fluo-
rescence resonance energy transfer. Proc Natl Acad Sci U S A. 2001; 98: 14464–14468. doi: 10.1073/
pnas.251422998 PMID: 11717404
57. Williams EC, Janmey PA, Ferry JD, Mosher DF. Conformational states of fibronectin. Effects of pH,
ionic strength, and collagen binding. J Biol Chem. 1982; 257: 14973–14978. PMID: 7174679
58. Rocco M, Carson M, Hantgan R, McDonagh J, Hermans J. Dependence of the shape of the plasma
fibronectin molecule on solvent composition. Ionic strength and glycerol content. J Biol Chem. 1983;
258: 14545–14549. PMID: 6643501
59. Lai CS, Wolff CE, Novello D, Griffone L, Cuniberti C, Molina F, et al. Solution structure of human
plasma fibronectin under different solvent conditions. Fluorescence energy transfer, circular dichroism
and light-scattering studies. J Mol Biol. 1993; 230: 625–640. S0022-2836(83)71174-5 [pii]. PMID:
8464068
60. Pelta J, Berry H, Fadda GC, Pauthe E, Lairez D. Statistical conformation of human plasma fibronectin.
Biochemistry. 2000; 39: 5146–5154. bi992770x [pii]. PMID: 10819982
61. Pauthe E, Pelta J, Patel S, Lairez D, Goubard F. Temperature-induced beta-aggregation of fibronectin
in aqueous solution. Biochim Biophys Acta. 2002; 1597: 12–21. S0167483802002716 [pii]. PMID:
12009397
62. Lai CS, Tooney NM, Ankel EG. Structure and flexibility of plasma fibronectin in solution: electron spin
resonance spin-label, circular dichroism, and sedimentation studies. Biochemistry. 1984; 23: 6393–
6397. PMID: 6099139
63. Patel S, Chaffotte AF, Goubard F, Pauthe E. Urea-induced sequential unfolding of fibronectin: a fluores-
cence spectroscopy and circular dichroism study. Biochemistry. 2004; 43: 1724–1735. doi: 10.1021/
bi0347104 PMID: 14769050
64. Benecky MJ, Kolvenbach CG, Wine RW, DiOrio JP, Mosesson MW. Human plasma fibronectin struc-
ture probed by steady-state fluorescence polarization: evidence for a rigid oblate structure. Biochemis-
try. 1990; 29: 3082–3091. PMID: 2337580
65. Sjoberg B, Pap S, Osterlund E, Osterlund K, Vuento M, Kjems J. Solution structure of human plasma
fibronectin using small-angle X-ray and neutron scattering at physiological pH and ionic strength. Arch
Biochem Biophys. 1987; 255: 347–353. PMID: 3592678
66. Lairez D, Pauthe E, Pelta J. Refolding of a high molecular weight protein: salt effect on collapse. Bio-
phys J. 2003; 84: 3904–3916. S0006-3495(03)75118-2 [pii]. PMID: 12770896
67. Alexander SS Jr, Colonna G, Edelhoch H. The structure and stability of human plasma cold-insoluble
globulin. J Biol Chem. 1979; 254: 1501–1505. PMID: 762148
68. Osterlund E, Eronen I, Osterlund K, Vuento M. Secondary structure of human plasma fibronectin: con-
formational change induced by calf alveolar heparan sulfates. Biochemistry. 1985; 24: 2661–2667.
PMID: 3161537
Allosteric Enhancement of Fn/α5β1 Affinity by FnBPA and BBK32
PLOSONE | DOI:10.1371/journal.pone.0159118 July 19, 2016 16 / 17
69. Khan MY, MedowMS, Newman SA. Unfolding transitions of fibronectin and its domains. Stabilization
and structural alteration of the N-terminal domain by heparin. Biochem J. 1990; 270: 33–38. PMID:
2396990
70. Brumfeld V, Werber MM. Studies on fibronectin and its domains. II. Secondary structure and spatial
configuration of fibronectin and of its domains. Arch Biochem Biophys. 1993; 302: 134–143. S0003-
9861(83)71191-4 [pii]. PMID: 8470891
71. Wolff CE, Lai CS. Inter-sulfhydryl distances in plasma fibronectin determined by fluorescence energy
transfer: effect of environmental factors. Biochemistry. 1990; 29: 3354–3361. PMID: 2334697
72. Takagi J, Strokovich K, Springer TA, Walz T. Structure of integrin alpha5beta1 in complex with fibronec-
tin. EMBO J. 2003; 22: 4607–4615. doi: 10.1093/emboj/cdg445 PMID: 12970173
73. Campbell ID, Humphries MJ. Integrin structure, activation, and interactions. Cold Spring Harb Perspect
Biol. 2011; 3: doi: 10.1101/cshperspect.a004994
74. Akiyama SK, Hasegawa E, Hasegawa T, Yamada KM. The interaction of fibronectin fragments with
fibroblastic cells. J Biol Chem. 1985; 260: 13256–13260. PMID: 2932436
75. Fraunholz M, Sinha B. Intracellular Staphylococcus aureus: live-in and let die. Front Cell Infect Micro-
biol. 2012; 2: 43. doi: 10.3389/fcimb.2012.00043 PMID: 22919634
76. Chen H, Ricklin D, Hammel M, Garcia BL, McWhorter WJ, Sfyroera G, et al. Allosteric inhibition of com-
plement function by a staphylococcal immune evasion protein. Proc Natl Acad Sci U S A. 2010; 107:
17621–17626. doi: 10.1073/pnas.1003750107 PMID: 20876141
77. Shattil SJ, Kim C, Ginsberg MH. The final steps of integrin activation: the end game. Nat Rev Mol Cell
Biol. 2010; 11: 288–300. doi: 10.1038/nrm2871 PMID: 20308986
78. Vogel V. Mechanotransduction involving multimodular proteins: converting force into biochemical sig-
nals. Annu Rev Biophys Biomol Struct. 2006; 35: 459–488. doi: 10.1146/annurev.biophys.35.040405.
102013 PMID: 16689645
79. Lower SK, Lamlertthon S, Casillas-Ituarte NN, Lins RD, Yongsunthon R, Taylor ES, et al. Polymor-
phisms in fibronectin binding protein A of Staphylococcus aureus are associated with infection of car-
diovascular devices. Proc Natl Acad Sci U S A. 2011; 108: 18372–18377. doi: 10.1073/pnas.
1109071108 PMID: 22025727
80. Xiong YQ, Sharma-Kuinkel BK, Casillas-Ituarte NN, Fowler VG Jr, Rude T, DiBartola AC, et al. Endo-
vascular infections caused by methicillin-resistant Staphylococcus aureus are linked to clonal complex-
specific alterations in binding and invasion domains of fibronectin-binding protein A as well as the
occurrence of fnbB. Infect Immun. 2015; 83: 4772–4780. doi: 10.1128/IAI.01074-15 PMID: 26416903
Allosteric Enhancement of Fn/α5β1 Affinity by FnBPA and BBK32
PLOSONE | DOI:10.1371/journal.pone.0159118 July 19, 2016 17 / 17
